KOBAYASHI Hirohito
   Department   School of Medicine(Tokyo Women's Medical University Adachi Medical Center), School of Medicine
   Position   Associate Professor
Article types Original article
Language English
Peer review Peer reviewed
Title Evaluation of renal function change during first-line tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma.
Journal Formal name:Japanese journal of clinical oncology
Abbreviation:Jpn J Clin Oncol
ISSN code:(1465-3621)0368-2811(Linking)
Volume, Issue, Page 47(12),pp.1175-1181
Author and coauthor Ishihara Hiroki, Kondo Tsunenori*, Fukuda Hironori, Yoshida Kazuhiko, Omae Kenji, Takagi Toshio, Iizuka Junpei, Kobayashi Hirohito, Tanabe Kazunari
Publication date 2017/12
Summary Deterioration of renal function was stronger with SU than SO. During SU therapy, renal function should be monitored and pre-treatment kidney function should be taken into consideration for therapy selection.
DOI 10.1093/jjco/hyx161
PMID 29140528